Sponsor Pipeline

Kallyope Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine		 Recruitment opened
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07645924 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment… Migraine Recruiting
NCT07674654 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine Acute Migraine Recruiting
Disease Areas
Migraine (2)
Get alerts when Kallyope Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free